George Washington University Clinical Trials
Sponsors / George Washington University
George Washington University appears as lead sponsor on 161 trial records in ClinicalTrials.gov. Of these, 19 are recruiting, 8 are active without new recruitment, and 106 have completed. The registry records 15 terminated or withdrawn trials for George Washington University. The most common reasons cited for termination include slow or insufficient recruitment, investigator or site changes. Planned participant enrollment across these trials sums to 79,674. Figures on this page are sourced from ClinicalTrials.gov and refreshed with each registry update.
161
Total Trials
19
Recruiting
8
Other Active
106
Completed
15
Terminated / Withdrawn
79,674
Total Enrollment
Termination reasons: Recruitment40% · Other40% · PI/or_Site13% · Regulatory7%
Recent Terminations
- HNSCC"Standard of care therapy for Stage III-IVA HNSCC updated in June to include neoadjuvant + adjuvant immunotherapy."
- Pain, Acute"not enough enrollment"
- Adiposity"Feasibility of subjects completing the 3 day high fat diet protocol and multiple oral glucose tests"
- Vestibular Disorder"Recruitment challenges for in-person visits of the affected population and a change in employment of the study team"
- Healthy Aging"Difficulty in recruitment within a reasonable timeframe. Primary Investigator has also moved institutions."
- Kidney Transplant; Complications"Lack of interest for continuing on by PI and issues with IRB"
- Breast Cancer"The benefit of completing the study was not worth exposing subjects to the risk during COVID. Delaying the return visits would make it difficult to analyze the changes in data overtime."
- Prostate Adenocarcinoma"Sponsor discontinued the drug"
- Burnout, Professional"COVID-19"
- Surgical Education"PI Left institution and did not transfer study to another PI"
Active Trials (8 total)
- NCT03288207
- NCT07249008
- NCT06525259
- Breast Cancer Stage I PHASE2NCT06806930
- Pulmonary Cancer PHASE4NCT05521789
- NCT06783400
- NCT06940362
- Vitamin B 12 Deficiency PHASE1NCT05426395
- NCT01206920
- NCT06483997
- NCT05301114
- NCT05616026
- NCT04483466
- Controlled Human Infection PHASE1NCT05706116
- Fracture PHASE4NCT07221019
- NCT00360893
- Coronary Artery Disease PHASE2NCT06620523
- NCT07201389
- NCT06186843
- Distal Radius Fractures PHASE1NCT06251206